Francisco Gómez‐García

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 123 citations · Full text

Classic Systemic Drugs, Psoriatic Arthritis, Clinical Dermatology +6

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 97 citations

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata

Ana Montilla, Francisco Gómez‐García, Pedro Jesús Gómez‐Arias et al. · Dermatology and Therapy · 2019 · 83 citations · Full text

Inflammation, Atopic Dermatitis, Medicine +5

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

J.M. Carrascosa, M. Vilavella, I. García‐Doval et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 75 citations

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

G. Carretero, E. Daudén, Francisco Vanaclocha Sebastián et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 65 citations · Full text